Medication info
Donggu Vildagliptin Tablets 50mg

Donggu Vildagliptin Tablets 50mg

Prescription medicationTabletOral
Ingredient · strength
Vildagliptin›50mg / 1 tablet
Manufacturer / importer
(Co., Ltd.) Donggu Bio Pharmaceuticals
Appearance
White to light yellow round tablets
Packaging
30 tablets/box [(10 tablets/Alu-Alu x 3)]
Approval status
Active

MFDS item code 202103149 · Approved 2021.04.16 · Insurance code 657308630

Summary

Main use
Improves glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
- This medicine may be administered as monotherapy or, in patients with no prior pharmacological treatment for diabetes, in combination with metformin at a dose of 50mg once daily in the morning or 100mg daily as 50mg twice daily in the morning and evening. - If adequate glycemic control cannot be achieved with metformin or a thiazolidinedione alone, the recommended dose when this medicine is administered in combination with metformin or a thiazolidinedione is 100mg daily, divided as 50mg twice daily in the morning and evening. - If adequate glycemic control cannot be achieved with a sulfonylurea alone, the recommended dose when this medicine is administered in combination with a sulfonylurea is 50mg once daily in the morning. In this patient group, vildagliptin 100mg once daily was not more effective than 50mg once daily. - If adequate glycemic control cannot be achieved with combination therapy of a sulfonylurea and metformin, the recommended dose when this medicine is administered in combination (as triple therapy) is 100mg daily, divided as 50mg twice daily in the morning and evening. - If adequate glycemic control cannot be achieved with insulin therapy (insulin alone or in combination with metformin), the recommended dose when this medicine is administered in combination is 100mg daily, divided as 50mg twice daily in the morning and evening. - This medicine may be taken with or without food, and doses exceeding 100mg daily are not recommended. - When this medicine is administered in combination with a sulfonylurea, a reduction in the dose of the sulfonylurea may be necessary to reduce the risk of hypoglycemia. - If you forget to take this medicine, take it as soon as you remember and take the next dose at the usual time. If you remember close to the time of your next dose, skip the missed dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment This medicine is not recommended for patients with hepatic impairment whose ALT or AST levels exceed 2.5 times the upper limit of normal before treatment. Patients with renal impairment - Patients with mild renal impairment (creatinine clearance ≥50mL/min): No dose adjustment is necessary. - Patients with moderate or severe renal impairment or end-stage renal disease (ESRD): A dose of 50mg once daily is recommended. (See section 2) under '3. General Precautions' in 'Precautions for Use.')

Ingredients

Manufacturer
(Co., Ltd.) Donggu Bio Pharmaceuticals

Efficacy & effects

Improves glycemic control in type 2 diabetes mellitus

  • Abnormal blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be administered alone or in combination with other medications to manage blood sugar more effectively. This helps maintain stable blood sugar levels and prevents complications of diabetes. Proper use according to the patient's condition supports healthy blood sugar control.

How to take

Adult dose

- This medicine may be administered as monotherapy or, in patients with no prior pharmacological treatment for diabetes, in combination with metformin at a dose of 50mg once daily in the morning or 100mg daily as 50mg twice daily in the morning and evening. - If adequate glycemic control cannot be achieved with metformin or a thiazolidinedione alone, the recommended dose when this medicine is administered in combination with metformin or a thiazolidinedione is 100mg daily, divided as 50mg twice daily in the morning and evening. - If adequate glycemic control cannot be achieved with a sulfonylurea alone, the recommended dose when this medicine is administered in combination with a sulfonylurea is 50mg once daily in the morning. In this patient group, vildagliptin 100mg once daily was not more effective than 50mg once daily. - If adequate glycemic control cannot be achieved with combination therapy of a sulfonylurea and metformin, the recommended dose when this medicine is administered in combination (as triple therapy) is 100mg daily, divided as 50mg twice daily in the morning and evening. - If adequate glycemic control cannot be achieved with insulin therapy (insulin alone or in combination with metformin), the recommended dose when this medicine is administered in combination is 100mg daily, divided as 50mg twice daily in the morning and evening. - This medicine may be taken with or without food, and doses exceeding 100mg daily are not recommended. - When this medicine is administered in combination with a sulfonylurea, a reduction in the dose of the sulfonylurea may be necessary to reduce the risk of hypoglycemia. - If you forget to take this medicine, take it as soon as you remember and take the next dose at the usual time. If you remember close to the time of your next dose, skip the missed dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment This medicine is not recommended for patients with hepatic impairment whose ALT or AST levels exceed 2.5 times the upper limit of normal before treatment. Patients with renal impairment - Patients with mild renal impairment (creatinine clearance ≥50mL/min): No dose adjustment is necessary. - Patients with moderate or severe renal impairment or end-stage renal disease (ESRD): A dose of 50mg once daily is recommended. (See section 2) under '3. General Precautions' in 'Precautions for Use.')

Precautions

This medication should not be used in patients with known allergic reactions to the active ingredient or any other component. This medication is not suitable for patients with type 1 diabetes or diabetic ketoacidosis. It should not be administered to patients with lactose intolerance, galactose intolerance, or certain genetic metabolic disorders. Abnormal liver function may occur rarely during treatment, so regular liver function tests should be conducted, and if liver enzyme levels rise significantly, the medication should be discontinued. Symptoms such as dizziness, headache, fatigue, dyspepsia, and hypoglycemia may occur while taking this medication, so caution is advised. Particular attention should be paid to hypoglycemia symptoms when using this medication in conjunction with drugs that can induce hypoglycemia, such as sulfonylureas or insulin, and dosage adjustment may be necessary as needed. In patients with heart failure and severely reduced cardiac function, the use of this medication is not recommended. If there are signs of skin blisters or ulcers, consult a doctor immediately, and if acute pancreatitis symptoms are suspected, discontinue use and visit a medical facility immediately. This medication is not considered safe for use in pregnant or nursing women and is not recommended for children or adolescents under 18 years of age. In the case of an overdose, there is no specific antidote, so supportive treatment is necessary, and the drug cannot be removed by dialysis. This medication should be stored out of reach of children and should not be transferred to another container.

Side effects

  • Hepatitis
  • liver dysfunction
  • elevated transaminase levels
  • angioedema
  • tremor
  • headache
  • dizziness
  • fatigue
  • nausea
  • hypoglycemia
Show 72 more
  • pharyngitis
  • myasthenia
  • constipation
  • weight gain
  • peripheral edema
  • gastroesophageal reflux
  • diarrhea
  • abdominal distension
  • chills
  • decreased blood glucose
  • sweating
  • pancreatitis
  • urticaria
  • blisters
  • exfoliative skin lesions
  • severe and disabling arthralgia
  • cutaneous vasculitis
  • cholecystitis
  • upper respiratory tract infection
  • acute myocardial infarction
  • nodular arrhythmia
  • acute cholecystitis
  • pneumothorax
  • cholelithiasis
  • femur fracture
  • peripheral artery occlusive disease
  • paroxysmal supraventricular tachycardia
  • congestive heart failure
  • gastric ulcer
  • gastric cancer
  • increased INR
  • appendicitis
  • pulmonary edema
  • vertigo
  • pruritus
  • xerostomia
  • vomiting
  • insomnia
  • dyspepsia
  • renal impairment
  • lip blisters
  • drowsiness
  • chest discomfort
  • hunger
  • sensory disturbance
  • spinal canal stenosis
  • abdominal pain
  • gastroenteritis
  • gastritis
  • gastric ulcer
  • belching
  • appendicitis
  • fatty liver
  • hyperkalemia
  • hypertriglyceridemia
  • heart failure
  • cardiomegaly
  • angina
  • cardiac arrest
  • renal cyst
  • lung cancer
  • leg pain
  • increased C-reactive protein
  • vesicular pemphigoid
  • myalgia
  • paresthesia
  • fever
  • edema
  • elevated creatine phosphokinase
  • elevated AST
  • increased C-reactive protein
  • elevated myoglobin levels

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly closed container in a cool place, i.e., at a temperature below 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be maintained and deterioration can be prevented.

Appearance and packaging

Appearance

White to light yellow round tablets

Package unit

30 tablets/box [(10 tablets/Alu-Alu x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.